logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
16/07/2025
Zhejiang Zhenyuan expressed on the interactive platform that the innovative new drug used for cancer pain treatment is still in the exploratory research stage, and there is currently no plan for it to be launched on the market.
Latest
1 m ago
Market news: Boeing is one of the primary targets of the EU's retaliation plan against the United States.
2 m ago
Analyst: UK long-term bond yields may continue to rise.
3 m ago
Vice President of China Council for the Promotion of International Trade, Li Qingshuang attended the meeting of the Standing Committee of the SCO Business Council.
3 m ago
China Eastern Airlines Corporation Limited (00670.HK) repurchased 2.5 million shares for 7.2631 million Hong Kong dollars on July 16th.
3 m ago
Guangshengtang: The innovative drug GST-HG131 for the treatment of hepatitis B has been included in the list of breakthrough therapies by the drug evaluation center, but this does not mean that it will be approved for market launch.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.